Financial insights of ABBV

MyFinsight

For the quarter ending 2026-03-31, ABBV made $15,002M in revenue. $695M in net income. Net profit margin of 4.63%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net revenues	15,002	16,618	15,776	15,423
Cost of products sold	4,218	4,552	5,304	4,346
Selling, general and administrative	3,578	3,895	3,569	3,253
Research and development	2,472	2,579	2,319	2,131
Acquired ipr&d and milestones	744	1,265	2,680	823
Other operating income	-	217	0	24
Total operating costs and expenses	11,012	12,074	13,872	10,529
Operating earnings	3,990	4,544	1,904	4,894
Interest expense, net	-645	-655	-667	-678
Net foreign exchange loss	-	-11	-20	-23
Other expense, net	-2,306	-1,210	-503	-2,639
Earnings before income tax expense	1,039	2,668	714	1,554
Income tax expense	342	853	526	613
Net earnings	697	1,815	188	941
Net earnings attributable to noncontrolling interest	2	-1	2	3
Net earnings attributable to abbvie inc	695	1,816	186	938

Basic EPS	0.39	1.025	0.1	0.52
Diluted EPS	0.39	1.022	0.1	0.52
Basic Average Shares	1,770,000,000	1,771,000,000	1,769,000,000	1,768,000,000
Diluted Average Shares	1,774,000,000	1,777,000,000	1,772,000,000	1,771,000,000

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.